Statistics
Publications
4
Citations
179
H-Index
4
Active since
2020
Rebecca Whiteley is an author at AstraZeneca (United Kingdom) specializing in oncology, potency optimization, and covalent inhibitor design.
Publications per year
2020–2023
4
4
AZD4625 is a Potent and Selective Inhibitor of KRASG12C
Atanu Chakraborty, Lyndsey Hanson, David M. Robinson et al. · Molecular Cancer Therapeutics · 2022 · 10 citations · Full text
Medicine, Oncology, Pharmacology +15
1–4 of 4